je.st
news
Tag: strategic
Qorvo Takes Strategic Stake in MEMS Vendor Cavendish
2015-08-28 20:30:00| Electronics - Topix.net
RF MEMS switch vendor Cavendish Kinetics Ltd. has raised $36 million in a Series-F round of financing that includes a $25 million stake taken by RF component company Qorvo Inc. through its subsidiary TriQuint Inc. The deal with Qorvo and TriQuint includes the terms under which Cavendish has granted TriQuint the exclusive right, but not the obligation, to acquire Cavendish with an option period lasting until June 30, 2017 or until 60 days after a certain undisclosed product enters pre-production, which ever is sooner. Qorvo Inc. was formed by the merger of two wireless semiconductor companies RF Micro Devices Inc. and TriQuint Inc. - which came into effect on Jan. 1, 2015.
Tags: takes
strategic
vendor
stake
Strategic Marketing is Way Forward for English Pig Producers
2015-08-28 02:00:00| ThePigSite - Industry News
UK - The English pig industry has sent an unequivocal message to Government — keep out of decisions about how the pig levy is spent.
Tags: english
marketing
forward
strategic
FGE And RBN Energy Form Strategic Alliance To Expand Client And Consulting Services
2015-08-24 03:39:40| chemicalonline Home Page
FGE and RBN Energy announced recently the formation of a strategic alliance between the two privately-held companies that will build upon each company’s capacity to deliver end-to-end global vision and insights on world oil, natural gas, and NGL markets
Tags: services
form
energy
client
Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors
2015-08-13 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & HOUSTON Clinical Trials to Evaluate Mercks KEYTRUDA (pembrolizumab) in Combination with Other Medicines and Treatments Across Multiple Tumor Types KENILWORTH, N.J. & HOUSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical research collaboration to evaluate Mercks anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel antitumor medicines. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orMerck Investor Relations:Justin Holko, 908-740-1879orMD Anderson Media Relations:Ron Gilmore, 713-745-1898Rlgilmore1@mdanderson.org Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: center
research
solid
cancer
Research And Markets: Strategic Analysis Of The Test Equipment Market For Software-Defined Radios (SDRs) 2015-2021 With 2014 As The Base Year
2015-08-11 06:51:59| rfglobalnet News Articles
Research and Markets has announced the addition of the "Strategic Analysis of the Test Equipment Market for Software-defined Radios (SDRs)" report to their offering.
Sites : [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] next »